SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-285284
Filing Date
2019-11-06
Accepted
2019-11-06 07:07:42
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826805d8k.htm   iXBRL 8-K 26881
2 EX-99.1 d826805dex991.htm EX-99.1 606994
6 GRAPHIC g826805g1105044445860.jpg GRAPHIC 2073
  Complete submission text file 0001193125-19-285284.txt   814064

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20191106.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20191106_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20191106_pre.xml EX-101.PRE 11849
11 EXTRACTED XBRL INSTANCE DOCUMENT d826805d8k_htm.xml XML 3599
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 191195045
SIC: 2834 Pharmaceutical Preparations